These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 22533731)

  • 21. Mucosal-associated invariant T-cell frequency and function in blood and liver of HCV mono- and HCV/HIV co-infected patients with advanced fibrosis.
    Beudeker BJB; van Oord GW; Arends JE; Schulze Zur Wiesch J; van der Heide MS; de Knegt RJ; Verbon A; Boonstra A; Claassen MAA
    Liver Int; 2018 Mar; 38(3):458-468. PubMed ID: 28792648
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Gammadelta T cell activation by chronic HIV infection may contribute to intrahepatic vdelta1 compartmentalization and hepatitis C virus disease progression independent of highly active antiretroviral therapy.
    Agrati C; D'Offizi G; Narciso P; Selva C; Pucillo LP; Ippolito G; Poccia F
    AIDS Res Hum Retroviruses; 2001 Sep; 17(14):1357-63. PubMed ID: 11602046
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antiretroviral therapy-associated modulation of Th1 and Th2 immune responses in HIV-infected pregnant women.
    Fiore S; Newell ML; Trabattoni D; Thorne C; Gray L; Savasi V; Tibaldi C; Ferrazzi E; Clerici M
    J Reprod Immunol; 2006 Jun; 70(1-2):143-50. PubMed ID: 16423410
    [TBL] [Abstract][Full Text] [Related]  

  • 24. T helper 1/T helper 2 cytokine imbalance in respiratory syncytial virus infection is associated with increased endogenous plasma cortisol.
    Pinto RA; Arredondo SM; Bono MR; Gaggero AA; Díaz PV
    Pediatrics; 2006 May; 117(5):e878-86. PubMed ID: 16618789
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Modulation of HCV replication after combination antiretroviral therapy in HCV/HIV co-infected patients.
    Sherman KE; Guedj J; Shata MT; Blackard JT; Rouster SD; Castro M; Feinberg J; Sterling RK; Goodman Z; Aronow BJ; Perelson AS
    Sci Transl Med; 2014 Jul; 6(246):246ra98. PubMed ID: 25101888
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intrahepatic mRNA expression in hepatitis C virus and HIV/hepatitis C virus co-infection: infiltrating cells, cytokines, and influence of HAART.
    Kuntzen T; Tural C; Li B; Feldmann G; Kupfer B; Nischalke HD; Clotet B; Sauerbruch T; Rockstroh JK; Spengler U
    AIDS; 2008 Jan; 22(2):203-10. PubMed ID: 18097222
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interleukin-27 is differentially associated with HIV viral load and CD4+ T cell counts in therapy-naïve HIV-mono-infected and HIV/HCV-co-infected Chinese.
    He L; Zhao J; Wang MH; Siu KK; Gan YX; Chen L; Zee BC; Yang L; Kung HF; Yang ZR; He ML
    PLoS One; 2014; 9(5):e96792. PubMed ID: 24816922
    [TBL] [Abstract][Full Text] [Related]  

  • 28. HCV Infection Amplified Th2 Bias and Th17 Responses In Schistosoma-Infected Patients.
    Nady S; Ezz A; El-Shorbagy A; Esmat G; Mt S
    Egypt J Immunol; 2016 Jan; 23(1):87-96. PubMed ID: 28502156
    [TBL] [Abstract][Full Text] [Related]  

  • 29. IMMUNOLOGICAL PROFILES IN HIV POSITIVE PATIENTS FOLLOWING HAART INITIATION IN KIGALI, RWANDA.
    Twizerimana AP; Mwatha J; Musabyimana JP; Kayigi E; Harelimana Jde D; Karanja SM; Mutesa L
    East Afr Med J; 2014 Aug; 91(8):261-6. PubMed ID: 26862650
    [TBL] [Abstract][Full Text] [Related]  

  • 30. HIV-1 alters T helper cytokines, interleukin-12 and interleukin-18 responses to the protozoan parasite Leishmania donovani.
    Wolday D; Berhe N; Britton S; Akuffo H
    AIDS; 2000 May; 14(8):921-9. PubMed ID: 10853973
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Interleukin (IL)-4, IL-10, IL-18 and IFN-gamma cytokines pattern in patients with combined hepatitis C virus and Schistosoma mansoni infections.
    El-Kady IM; Lotfy M; Badra G; El-Masry S; Waked I
    Scand J Immunol; 2005 Jan; 61(1):87-91. PubMed ID: 15644127
    [TBL] [Abstract][Full Text] [Related]  

  • 32. HIV and hepatitis C co-infection: the role of HAART in HIV/hepatitis C virus management.
    Jones M; Núñez M
    Curr Opin HIV AIDS; 2011 Nov; 6(6):546-52. PubMed ID: 22001896
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Systemic cytokine and interferon responsiveness Patterns in HIV and HCV mono and co-infections.
    Fernandez-Botran R; Joshi-Barve S; Ghare S; Barve S; Young M; Plankey M; Bordon J
    J Interferon Cytokine Res; 2014 Nov; 34(11):885-93. PubMed ID: 24955730
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Alterations of NK cell frequency and function in HIV/HCV co-infected patients].
    Zhang X; Zhao P; Kang FB; Zhang XW; Si C; Chen XL; Chen WW; Zhao M
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2011 Aug; 25(4):248-50. PubMed ID: 22106474
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Transient liver injury associated with the early recovery of HCV-specific T-cell responses and HCV rebound in HIV-1/HCV coinfected patients undergoing highly active antiretroviral therapy.
    Kang F; Chen W; Zhang X; Nie W; Fu J; Xu X; Zhao P; Zhang X; Li W; Wang FS; Zhang Z; Zhao M
    J Acquir Immune Defic Syndr; 2013 Feb; 62(2):135-42. PubMed ID: 23075912
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact of Hepatitis C Virus on the Circulating Levels of IL-7 in HIV-1 Coinfected Women.
    Kerzerho J; McIlvaine EJ; Anthony P; Mack WJ; Wang CH; Frederick T; Operskalski E; Chen Z; Al-Harthi L; Landay A; Young MA; Tien PC; Augenbraun M; Strickler HD; Akbari O; Golub ET; Sharp GB; Kovacs A
    J Acquir Immune Defic Syndr; 2016 Feb; 71(2):172-80. PubMed ID: 26761519
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [A preliminary assessment of the clinical utility of measuring hepatitis C virus antibody to evaluate infection status].
    Long L; Liu Y; Duan Z; Xu Q; Shen T; Dou X; Zhuang H; Lu F
    Zhonghua Gan Zang Bing Za Zhi; 2014 Apr; 22(4):244-50. PubMed ID: 25173220
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dynamic changes of Th1/Th2/Th17 cytokines and human beta defensin 2 in HIV-infected patients with oral candidiasis during the first year of highly active anti-retroviral therapy.
    Yong X; Liu Z; Jiang L; Tao R; Liu W; Zhang L; Peng Y; Lin X; Huang Y
    Arch Oral Biol; 2018 Aug; 92():62-67. PubMed ID: 29753928
    [TBL] [Abstract][Full Text] [Related]  

  • 39. More improvement than progression of liver fibrosis following antiretroviral therapy in a longitudinal cohort of HIV-infected patients with or without HBV and HCV co-infections.
    Ding Y; Duan S; Ye R; Yang Y; Yao S; Wang J; Cao D; Liu X; Lu L; Jia M; Wu Z; He N
    J Viral Hepat; 2017 May; 24(5):412-420. PubMed ID: 27925409
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Is antiretroviral therapy causing long-term liver damage? A comparative analysis of HIV-mono-infected and HIV/hepatitis C co-infected cohorts.
    Moodie EE; Pant Pai N; Klein MB
    PLoS One; 2009; 4(2):e4517. PubMed ID: 19223976
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.